Sara I. Broek-Den
Copenhagen, 2100, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier.
Journal: Molecular pharmaceutics
Published: November 06, 2025
Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti-Amyloid-β Antibody.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 04, 2025
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine.
Journal: Translational neurodegeneration
Published: July 29, 2025
Brain-penetrating peptide and antibody radioligands for proof-of-concept PET imaging of fibrin in Alzheimer's disease.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 04, 2025
Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology.
Journal: ACS pharmacology & translational science
Published: May 17, 2025
High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose.
Journal: Fluids and barriers of the CNS
Published: May 04, 2025
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease.
Journal: The journal of prevention of Alzheimer's disease
Published: April 11, 2025
PET imaging of TREM2 in amyloid-beta induced neuroinflammation.
Journal: European journal of nuclear medicine and molecular imaging
Published: February 05, 2025
Radiolabeled albumin through SNAr of cysteines as a potential pretargeting theranostic agent.
Journal: RSC advances
Published: October 11, 2022
Pretargeted imaging beyond the blood-brain barrier.
Journal: RSC medicinal chemistry
Published: October 02, 2022
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein.
Journal: Frontiers in nuclear medicine
Published: August 31, 2022
Last Updated: 09/26/2026